Finance

Lists
CLBIO:STO
Corline Biomedical AB
SEK 16.05
-0.62%
(-0.10) 1D
Sep 4, 5:24:24 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for CLBIO...
Open
SEK 16.45
High
SEK 16.45
Low
SEK 15.50
Mkt. cap
419.44M
Avg. vol.
8.91K
Volume
10.52K
52-wk high
SEK 27.20
52-wk low
SEK 14.00
EPS
-SEK 0.49
Shares outstanding
26.13M
No. of employees
13
Open
SEK 16.45
High
SEK 16.45
Low
SEK 15.50
Mkt. cap
419.44M
Avg. vol.
8.91K
Volume
10.52K
52-wk high
SEK 27.20
52-wk low
SEK 14.00
EPS
-SEK 0.49
Shares outstanding
26.13M
No. of employees
13
About Corline Biomedical AB
CEOHenrik Nittmar
Employees13
Founded1991
Headquarters-
SectorPharmaceutical industry
Websitecorline.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.30M
2.10M
4.29M
4.75M
Cost of goods sold
631.00K
716.00K
-79.00K
139.00K
Cost of revenue
631.00K
716.00K
-79.00K
139.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.07M
6.47M
6.79M
6.00M
Operating expense
4.04M
6.46M
6.87M
6.01M
Total operating expenses
4.67M
7.17M
6.80M
6.15M
Operating income
-3.37M
-5.07M
-2.50M
-1.40M
Other non operating income
9.00K
-30.00K
2.00K
-
EBT including unusual items
-3.36M
-5.03M
-2.50M
-1.44M
EBT excluding unusual items
-3.36M
-5.03M
-2.50M
-1.40M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-44.00K
-30.00K
61.00K
4.00K
Net income
-3.36M
-5.03M
-2.50M
-1.44M
Net profit margin
-257.39%
-238.93%
-58.28%
-30.20%
Earnings per share
-
-
-
-
Interest and investment income
1.00K
38.00K
1.00K
-
Interest expense
-1.00K
-
-
-4.00K
Net interest expenses
-
38.00K
1.00K
-4.00K
Depreciation and amortization charges
12.00K
20.00K
20.00K
-
EBITDA
-3.36M
-5.03M
-2.48M
-1.36M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps